UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003819
Receipt number R000004604
Scientific Title A phase ll study of combination therapy with Panitumumab plus CPT-11 for advanced and/or recurrent colon-rectal cancer with wild type KRAS which has prior therapy of fluoropylimidine, oxaliplatin or CPT-11 (OGSG 1001)
Date of disclosure of the study information 2010/07/15
Last modified on 2020/01/05 13:38:53

No. Disposal Last modified on Item of update
1 Insert 2010/06/24 18:48:41
2 Update 2010/08/04 18:01:12 Name of person sending information
Name of person sending information
Address
3 Update 2010/10/25 16:05:22 Recruitment status
4 Update 2010/10/25 16:06:28 Acronym
Acronym
5 Update 2010/10/25 16:09:42 Organization
Organization
Division name
Division name
Address
TEL
Name of person sending information
6 Update 2011/03/04 17:26:06 Last follow-up date
7 Update 2011/11/22 19:06:44 Institute
Institute
Post marketing survey by drug manufacture etc., specified by Japanese law.
8 Update 2012/06/24 23:08:21 Public title
Public title
Acronym
Acronym
9 Update 2012/06/24 23:12:14 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization1
Address1
Tel1
Email1
10 Update 2012/07/24 20:51:14 Recruitment status
Last follow-up date
11 Update 2013/06/24 22:37:27 Anticipated trial start date
12 Update 2014/06/25 14:33:50 Recruitment status
13 Update 2014/07/27 22:42:18 Date analysis concluded
14 Update 2015/06/11 23:31:27 Last name of lead principal investigator
Last name of lead principal investigator
Email
Email
Email
15 Update 2015/06/19 21:05:59 Results
Results
16 Update 2018/04/30 23:06:40 Email
Email
Name of primary person or sponsor
Organization
17 Update 2018/04/30 23:15:10 Organization
18 Update 2018/04/30 23:17:46 Organization
19 Update 2018/05/10 20:21:56 Email
Email
20 Update 2020/01/05 13:38:53 Date of IRB